Evaluation of diagnostic efficiency of the new enzyme immunoassay for detection of IgM antibodies to Hepatitis B core antigen by OF Fedorova et al.
POSTER PRESENTATION Open Access
Evaluation of diagnostic efficiency of the new
enzyme immunoassay for detection of IgM
antibodies to Hepatitis B core antigen
OF Fedorova1*, NM Khodak1, NA Bugrova1, VF Puzyrev1, AN Burkov1,2, TI Ulanova1,2
From Abstracts from International Symposium HIV and Emerging Infectious Diseases 2014
Marseille, France. 21-23 May 2013
Introduction
Recently, many studies are available about the detection
of viral DNA in sera containing IgM to HBcAg in the
absence of HBsAg, which lead to increase the risk of
transmission of HBV, what is especially important for
blood transfusion and the use of blood products. In this
regard, it is important to use highly sensitive ELISA test
for detection of IgM against HBcAg which could help to
eliminate the risk of transmission of HBV, especially
during the «serological window».
Aim
To assess the diagnostic efficiency of the new high sen-
sitive test for the IgM to the core antigen of HBV detec-
tion with the aim to use it for early diagnostic Hepatitis
B virus.
Materials and methods
Analytical sensitivity of the kit was evaluated using stan-
dard of Paul-Ehrlich Institut - HBc-Referenzserum-IgM
84 (IgM anti-HBc). Diagnostic sensitivity of the kit was
evaluated using samples of Anti-HBc IgM Performance
Panel PHE203 (BBI), four seroconversion panels pro-
duced by ZeptoMetrix and BBI (USA) and 264 positive
samples from patients with HBV at various stages. Diag-
nostic specificity was evaluated by testing different cate-
gories of the population: primary donors (n=1056),
clinical patients (n=386), potentially cross-reacting sam-
ples (n=509). Diagnostic efficiency of the kit was evalu-
ated in comparison with the reference kits with the
analytical sensitivity of 25-50 U/ml PEI.
Results
Analytical sensitivity of the new test is ≤10 U/ml PEI. The
seroconversion panels study has found that the kit detects
56 positive samples out of 92 seroconversion samples,
compared with commercial reference assays, which detect
46 samples. The diagnostic sensitivity of the developed
assay is 100% (264/264) compare to the 41% (108/264) of
the reference test that may be caused by higher sensitivity
level of the new test in comparison with the reference test.
Diagnostic specificity of the kit is 99.6%.
Conclusion
High sensitivity and specificity of the new test provide
more effective anti-IgM detection which is important for
the diagnostic of the current or past infection of HBV.
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